Abbott Expands Zemplar Market With Oral Form For Pre-Dialysis Patients
Abbott will launch the oral form of its vitamin D analogue Zemplar (paricalcitol) in mid-June following FDA approval May 26
Abbott will launch the oral form of its vitamin D analogue Zemplar (paricalcitol) in mid-June following FDA approval May 26